A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease

Clinical trial NCT00059280 · COMPLETED

Trial details

NCT number: NCT00059280
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II

Start date: 2003-04-01
Primary completion: 2005-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.